215 related articles for article (PubMed ID: 31981888)
1. Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders.
Stormezand GN; Chaves LT; Vállez García D; Doorduin J; De Jong BM; Leenders KL; Kremer BPH; Dierckx RAJO
Neuroimage Clin; 2020; 25():102161. PubMed ID: 31981888
[TBL] [Abstract][Full Text] [Related]
2. Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders.
Jaimini A; Tripathi M; D'Souza MM; Panwar P; Sharma R; Mehta S; Pandey S; Saw S; Singh D; Solanki Y; Mishra AK; Mondal A
Nucl Med Commun; 2013 May; 34(5):426-31. PubMed ID: 23458855
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
Burn DJ; Sawle GV; Brooks DJ
J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):278-84. PubMed ID: 8158173
[TBL] [Abstract][Full Text] [Related]
4. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
5. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
[TBL] [Abstract][Full Text] [Related]
6. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O
Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757
[TBL] [Abstract][Full Text] [Related]
7. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
Kuwabara H; Cumming P; Yasuhara Y; Léger GC; Guttman M; Diksic M; Evans AC; Gjedde A
J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
[TBL] [Abstract][Full Text] [Related]
8. [Clinical utility of (18)F-DOPA-PET in movement disorders. A systematic review].
Puñal-Riobóo J; Serena-Puig A; Varela-Lema L; Alvarez-Páez AM; Ruano-Ravina A
Rev Esp Med Nucl; 2009; 28(3):106-13. PubMed ID: 19558950
[TBL] [Abstract][Full Text] [Related]
9. Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study.
Nurmi E; Ruottinen HM; Bergman J; Haaparanta M; Solin O; Sonninen P; Rinne JO
Mov Disord; 2001 Jul; 16(4):608-15. PubMed ID: 11481683
[TBL] [Abstract][Full Text] [Related]
10. Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.
Otsuka M; Ichiya Y; Hosokawa S; Kuwabara Y; Tahara T; Fukumura T; Kato M; Masuda K; Goto I
J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):898-904. PubMed ID: 1744644
[TBL] [Abstract][Full Text] [Related]
11. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Antonini A; Leenders KL; Vontobel P; Maguire RP; Missimer J; Psylla M; Günther I
Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
[TBL] [Abstract][Full Text] [Related]
12. Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
Criswell SR; Perlmutter JS; Videen TO; Moerlein SM; Flores HP; Birke AM; Racette BA
Neurology; 2011 Apr; 76(15):1296-301. PubMed ID: 21471467
[TBL] [Abstract][Full Text] [Related]
13. [18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study.
Kuten J; Linevitz A; Lerman H; Freedman N; Kestenbaum M; Shiner T; Giladi N; Even-Sapir E
J Integr Neurosci; 2020 Sep; 19(3):489-494. PubMed ID: 33070528
[TBL] [Abstract][Full Text] [Related]
14. Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.
Brück A; Aalto S; Nurmi E; Vahlberg T; Bergman J; Rinne JO
Mov Disord; 2006 Jul; 21(7):958-63. PubMed ID: 16550545
[TBL] [Abstract][Full Text] [Related]
15. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
Pal PK; Leung J; Hedrich K; Samii A; Lieberman A; Nausieda PA; Calne DB; Breakefield XO; Klein C; Stoessl AJ
Mov Disord; 2002 Jul; 17(4):789-94. PubMed ID: 12210877
[TBL] [Abstract][Full Text] [Related]
16. [
Criswell SR; Nielsen SS; Warden M; Perlmutter JS; Moerlein SM; Flores HP; Huang J; Sheppard L; Seixas N; Checkoway H; Racette BA
Neurotoxicology; 2018 Jan; 64():43-49. PubMed ID: 28694016
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET.
Huang WS; Ma KH; Chou YH; Chen CY; Liu RS; Liu JC
Nucl Med Commun; 2003 Jan; 24(1):77-83. PubMed ID: 12501023
[TBL] [Abstract][Full Text] [Related]
18. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
Nurmi E; Bergman J; Eskola O; Solin O; Vahlberg T; Sonninen P; Rinne JO
Synapse; 2003 Jun; 48(3):109-15. PubMed ID: 12645035
[TBL] [Abstract][Full Text] [Related]
19. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
Jokinen P; Helenius H; Rauhala E; Brück A; Eskola O; Rinne JO
J Nucl Med; 2009 Jun; 50(6):893-9. PubMed ID: 19443601
[TBL] [Abstract][Full Text] [Related]
20. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
